Sort by
Becoming a substantial holder
Application for quotation of securities - SPL
Details of Company Address
Quarterly Activities/Appendix 4C Cash Flow Report
$3.5 Million R&D Tax Incentive Received
Starpharma Investor Presentation Petalion Webinar
Starpharma secures majority ownership of Petalion
Trading Halt
Change in substantial holding
Notice of Annual General Meeting/Proxy Form
| Date | Headline |
|---|---|
3 Nov 2026 | Becoming a substantial holder |
30 Oct 2026 | Application for quotation of securities - SPL |
23 Oct 2026 | Details of Company Address |
22 Oct 2026 | Quarterly Activities/Appendix 4C Cash Flow Report |
22 Oct 2026 | $3.5 Million R&D Tax Incentive Received |
21 Oct 2026 | Starpharma Investor Presentation Petalion Webinar |
20 Oct 2026 | Starpharma secures majority ownership of Petalion |
16 Oct 2026 | Trading Halt |
7 Oct 2026 | Change in substantial holding |
6 Oct 2026 | Notice of Annual General Meeting/Proxy Form |
